These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 24440405

  • 1. Antiglioma activity of GoPI-sugar, a novel gold(I)-phosphole inhibitor: chemical synthesis, mechanistic studies, and effectiveness in vivo.
    Jortzik E, Farhadi M, Ahmadi R, Tóth K, Lohr J, Helmke BM, Kehr S, Unterberg A, Ott I, Gust R, Deborde V, Davioud-Charvet E, Réau R, Becker K, Herold-Mende C.
    Biochim Biophys Acta; 2014 Aug; 1844(8):1415-26. PubMed ID: 24440405
    [Abstract] [Full Text] [Related]

  • 2. Mechanistic studies on a novel, highly potent gold-phosphole inhibitor of human glutathione reductase.
    Deponte M, Urig S, Arscott LD, Fritz-Wolf K, Réau R, Herold-Mende C, Koncarevic S, Meyer M, Davioud-Charvet E, Ballou DP, Williams CH, Becker K.
    J Biol Chem; 2005 May 27; 280(21):20628-37. PubMed ID: 15792952
    [Abstract] [Full Text] [Related]

  • 3. Repurposing Auranofin and Evaluation of a New Gold(I) Compound for the Search of Treatment of Human and Cattle Parasitic Diseases: From Protozoa to Helminth Infections.
    Feng L, Pomel S, Latre de Late P, Taravaud A, Loiseau PM, Maes L, Cho-Ngwa F, Bulman CA, Fischer C, Sakanari JA, Ziniel PD, Williams DL, Davioud-Charvet E.
    Molecules; 2020 Nov 01; 25(21):. PubMed ID: 33139647
    [Abstract] [Full Text] [Related]

  • 4. A sugar-modified phosphole gold complex with antiproliferative properties acting as a thioredoxin reductase inhibitor in MCF-7 cells.
    Viry E, Battaglia E, Deborde V, Müller T, Réau R, Davioud-Charvet E, Bagrel D.
    ChemMedChem; 2008 Nov 01; 3(11):1667-70. PubMed ID: 18759235
    [No Abstract] [Full Text] [Related]

  • 5. Cancer cell death induced by phosphine gold(I) compounds targeting thioredoxin reductase.
    Gandin V, Fernandes AP, Rigobello MP, Dani B, Sorrentino F, Tisato F, Björnstedt M, Bindoli A, Sturaro A, Rella R, Marzano C.
    Biochem Pharmacol; 2010 Jan 15; 79(2):90-101. PubMed ID: 19665452
    [Abstract] [Full Text] [Related]

  • 6. Anticancer therapeutics that target selenoenzymes: synthesis, characterization, in vitro cytotoxicity, and thioredoxin reductase inhibition of a series of gold(I) complexes containing hydrophilic phosphine ligands.
    Vergara E, Casini A, Sorrentino F, Zava O, Cerrada E, Rigobello MP, Bindoli A, Laguna M, Dyson PJ.
    ChemMedChem; 2010 Jan 15; 5(1):96-102. PubMed ID: 19937669
    [Abstract] [Full Text] [Related]

  • 7. Benzimidazol-2-ylidene gold(I) complexes are thioredoxin reductase inhibitors with multiple antitumor properties.
    Rubbiani R, Kitanovic I, Alborzinia H, Can S, Kitanovic A, Onambele LA, Stefanopoulou M, Geldmacher Y, Sheldrick WS, Wolber G, Prokop A, Wölfl S, Ott I.
    J Med Chem; 2010 Dec 23; 53(24):8608-18. PubMed ID: 21082862
    [Abstract] [Full Text] [Related]

  • 8. Antiglioma activity of 2,2':6',2"-terpyridineplatinum(II) complexes in a rat model--effects on cellular redox metabolism.
    Ahmadi R, Urig S, Hartmann M, Helmke BM, Koncarevic S, Allenberger B, Kienhoefer C, Neher M, Steiner HH, Unterberg A, Herold-Mende C, Becker K.
    Free Radic Biol Med; 2006 Mar 01; 40(5):763-78. PubMed ID: 16520229
    [Abstract] [Full Text] [Related]

  • 9. Synthesis and characterization of azolate gold(I) phosphane complexes as thioredoxin reductase inhibiting antitumor agents.
    Galassi R, Burini A, Ricci S, Pellei M, Rigobello MP, Citta A, Dolmella A, Gandin V, Marzano C.
    Dalton Trans; 2012 May 07; 41(17):5307-18. PubMed ID: 22391922
    [Abstract] [Full Text] [Related]

  • 10. Anticancer profile of a series of gold(III) (2-phenyl)pyridine complexes.
    Rubbiani R, Zehnder TN, Mari C, Blacque O, Venkatesan K, Gasser G.
    ChemMedChem; 2014 Dec 07; 9(12):2781-90. PubMed ID: 25377650
    [Abstract] [Full Text] [Related]

  • 11. Double-drug development against antioxidant enzymes from Plasmodium falciparum.
    Biot C, Dessolin J, Grellier P, Davioud-Charvet E.
    Redox Rep; 2003 Dec 07; 8(5):280-3. PubMed ID: 14962365
    [Abstract] [Full Text] [Related]

  • 12. A study of the relative importance of the peroxiredoxin-, catalase-, and glutathione-dependent systems in neural peroxide metabolism.
    Mitozo PA, de Souza LF, Loch-Neckel G, Flesch S, Maris AF, Figueiredo CP, Dos Santos AR, Farina M, Dafre AL.
    Free Radic Biol Med; 2011 Jul 01; 51(1):69-77. PubMed ID: 21440059
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of both thioredoxin reductase and glutathione reductase may contribute to the anticancer mechanism of TH-302.
    Li S, Zhang J, Li J, Chen D, Matteucci M, Curd J, Duan JX.
    Biol Trace Elem Res; 2010 Sep 01; 136(3):294-301. PubMed ID: 19838642
    [Abstract] [Full Text] [Related]

  • 14. Noble metal targeting of thioredoxin reductase--covalent complexes with thioredoxin and thioredoxin-related protein of 14 kDa triggered by cisplatin.
    Prast-Nielsen S, Cebula M, Pader I, Arnér ES.
    Free Radic Biol Med; 2010 Dec 01; 49(11):1765-78. PubMed ID: 20851179
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. PQ401, an IGF-1R inhibitor, induces apoptosis and inhibits growth, proliferation and migration of glioma cells.
    Zhou X, Zhao X, Li X, Ping G, Pei S, Chen M, Wang Z, Zhou W, Jin B.
    J Chemother; 2016 Dec 01; 28(1):44-9. PubMed ID: 25971682
    [Abstract] [Full Text] [Related]

  • 19. Antitumor activity of gold(III)-dithiocarbamato derivatives on prostate cancer cells and xenografts.
    Cattaruzza L, Fregona D, Mongiat M, Ronconi L, Fassina A, Colombatti A, Aldinucci D.
    Int J Cancer; 2011 Jan 01; 128(1):206-15. PubMed ID: 20209498
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.